| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), ENVB's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 70.4K | - | - | |
| CFO | 47.4K | - | - | |
| Dir | 7.9K | - | - | |
| Dir | 7.9K | - | - | |
| Dir | 7.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Pasqualone Frank | Director | Buy | 1,000 | $2.14 | $2,140.00 | New | -35.5% | -78.0% | |
| Nov 16, 2018 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 | 10% Owner | Sell | 100,000 | $0.30 | $29,549.64 | -4.3% | - | - | |
| Nov 16, 2018 | Lokesh Sikaria Trust Dated 12/14/2012 | 10% Owner | Sell | 100,000 | $0.30 | $29,549.64 | -4.3% | - | - | |
| Nov 16, 2018 | Sikaria Chanda | 10% Owner | Sell | 100,000 | $0.30 | $29,549.64 | -4.3% | - | - | |
| Nov 16, 2018 | Sikaria Lokesh | 10% Owner | Sell | 100,000 | $0.30 | $29,549.64 | -4.3% | - | - | |
| Jul 17, 2018 | Devanur Giri | 10% Owner | Sell | 429,357 | $2.07 | $887,945.92 | -19.6% | - | - | |
| Nov 17, 2017 | Devanur Giri | President &CEO | Buy | 12,121 | $4.12 | $49,877.92 | +0.6% | - | - | |
| Nov 17, 2017 | Rai Dhruwa N | Director | Buy | 145,450 | $4.12 | $598,526.75 | +28.9% | - | - | |
| Nov 17, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 100,000 | $4.12 | $411,500.00 | +3.5% | - | - | |
| Oct 30, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 3,803 | $6.50 | $24,718.72 | +37.6% | - | - |